These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19053961)

  • 1. Delayed neovascularization in inflammation-induced corneal neovascularization in interleukin-10-deficient mice.
    Samolov B; Kvanta A; van der Ploeg I
    Acta Ophthalmol; 2010 Mar; 88(2):251-6. PubMed ID: 19053961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist.
    Lu P; Li L; Liu G; Zhang X; Mukaida N
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4761-8. PubMed ID: 19458323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice.
    Samolov B; Steen B; Seregard S; van der Ploeg I; Montan P; Kvanta A
    Exp Eye Res; 2005 Feb; 80(2):159-66. PubMed ID: 15670794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
    Zuo L; Fan Y; Wang F; Gu Q; Xu X
    Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils promote experimental choroidal neovascularization.
    Zhou J; Pham L; Zhang N; He S; Gamulescu MA; Spee C; Ryan SJ; Hinton DR
    Mol Vis; 2005 Jun; 11():414-24. PubMed ID: 15988410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice.
    Fujita S; Saika S; Kao WW; Fujita K; Miyamoto T; Ikeda K; Nakajima Y; Ohnishi Y
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3051-5. PubMed ID: 17591872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.
    Amano S; Rohan R; Kuroki M; Tolentino M; Adamis AP
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):18-22. PubMed ID: 9430540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite roles of CCR2 and CX3CR1 macrophages in alkali-induced corneal neovascularization.
    Lu P; Li L; Liu G; van Rooijen N; Mukaida N; Zhang X
    Cornea; 2009 Jun; 28(5):562-9. PubMed ID: 19421039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of nuclear factor kappa B in inflammation-induced rat corneal neovascularization.
    Zhang MC; Wang Y; Yang Y
    Ocul Immunol Inflamm; 2006 Dec; 14(6):359-65. PubMed ID: 17162607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of macrophage migration inhibitory factor in corneal neovascularization.
    Usui T; Yamagami S; Kishimoto S; Seiich Y; Nakayama T; Amano S
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3545-50. PubMed ID: 17652722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
    Azar DT
    Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization.
    Zhu SN; Dana MR
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1427-34. PubMed ID: 10359324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization.
    Kvanta A; Sarman S; Fagerholm P; Seregard S; Steen B
    Exp Eye Res; 2000 Apr; 70(4):419-28. PubMed ID: 10865990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired angiogenic response in the corneas of mice lacking osteopontin.
    Fujita N; Fujita S; Okada Y; Fujita K; Kitano A; Yamanaka O; Miyamoto T; Kon S; Uede T; Rittling SR; Denhardt DT; Saika S
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):790-4. PubMed ID: 19741245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice.
    Inomata Y; Fukushima M; Hara R; Takahashi E; Honjo M; Koga T; Kawaji T; Satoh H; Takeya M; Sawamura T; Tanihara H
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3970-6. PubMed ID: 19182261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization.
    Dell S; Peters S; Müther P; Kociok N; Joussen AM
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1928-37. PubMed ID: 16639000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired angiogenic response in the cornea of mice lacking tenascin C.
    Sumioka T; Fujita N; Kitano A; Okada Y; Saika S
    Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2462-7. PubMed ID: 21087965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis.
    Zhang H; Li C; Baciu PC
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):955-62. PubMed ID: 11923234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase-II is expressed in severe corneal alkali burns and inhibits neovascularization.
    Sennlaub F; Courtois Y; Goureau O
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2773-9. PubMed ID: 10549635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.